Literature DB >> 18080167

Hyperammonemic encephalopathy caused by carnitine deficiency.

Berkeley N Limketkai1, Stephen D Zucker.   

Abstract

Carnitine is an essential co-factor in fatty acid metabolism. Carnitine deficiency can impair fatty acid oxidation, rarely leading to hyperammonemia and encephalopathy. We present the case of a 35-year-old woman who developed acute mental status changes, asterixis, and diffuse muscle weakness. Her ammonia level was elevated at 276 microg/dL. Traditional ammonia-reducing therapies were initiated, but proved ineffective. Pharmacologic, microbial, and autoimmune causes for the hyperammonemia were excluded. The patient was severely malnourished and her carnitine level was found to be extremely low. After carnitine supplementation, ammonia levels normalized and the patient's mental status returned to baseline. In the setting of refractory hyperammonemia, this case illustrates how careful investigation may reveal a treatable condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080167      PMCID: PMC2359173          DOI: 10.1007/s11606-007-0473-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  36 in total

1.  Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry.

Authors:  B Wilcken; V Wiley; K G Sim; K Carpenter
Journal:  J Pediatr       Date:  2001-04       Impact factor: 4.406

2.  Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.

Authors:  H M Hamer; S Knake; U Schomburg; F Rosenow
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

3.  Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.

Authors:  W Röschinger; A C Muntau; M Duran; L Dorland; L IJlst; R J Wanders; A A Roscher
Journal:  Clin Chim Acta       Date:  2000-08       Impact factor: 3.786

4.  Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency.

Authors:  A Koizumi; J Nozaki; T Ohura; T Kayo; Y Wada; J Nezu; R Ohashi; I Tamai; Y Shoji; G Takada; S Kibira; T Matsuishi; A Tsuji
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

5.  Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation.

Authors:  M G Mutchnick; E Lerner; H O Conn
Journal:  Gastroenterology       Date:  1974-05       Impact factor: 22.682

6.  Regulation of mitochondrial carbamoyl-phosphate synthetase 1 activity by active site fatty acylation.

Authors:  M M Corvi; C L Soltys; L G Berthiaume
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

7.  Correlation of carnitine levels to methionine and lysine intake.

Authors:  M Krajcovicová-Kudlácková; R Simoncic; A Béderová; K Babinská; I Béder
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

Review 8.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.

Authors:  C-M Lokrantz; B Eriksson; I Rosén; F Asztely
Journal:  Acta Neurol Scand       Date:  2004-04       Impact factor: 3.209

Review 10.  Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine.

Authors:  Martha H Stipanuk
Journal:  Annu Rev Nutr       Date:  2004       Impact factor: 11.848

View more
  22 in total

1.  Micronutrient-related neurologic complications following bariatric surgery.

Authors:  Ali Kazemi; Thomas Frazier; Matt Cave
Journal:  Curr Gastroenterol Rep       Date:  2010-08

2.  Fatal Hyperammonemic Encephalopathy in a Pediatric Patient After Roux-en-Y Gastric Bypass.

Authors:  Patrick C Bonasso; Melvin S Dassinger
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

Review 3.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

4.  Refeeding encephalopathy in a patient with severe hypophosphataemia and hyperammonaemia.

Authors:  S Becker; G Dam; C L Hvas
Journal:  Eur J Clin Nutr       Date:  2014-11-12       Impact factor: 4.016

Review 5.  Acetyl-L-carnitine in hepatic encephalopathy.

Authors:  Michele Malaguarnera
Journal:  Metab Brain Dis       Date:  2013-02-08       Impact factor: 3.584

6.  Failure of carnitine in improving hepatic nitrogen content in alcoholic and non-alcoholic malnourished rats.

Authors:  Luciana P Rodrigues; Guilherme Vannucchi Portari; Gilberto João Padovan; Alceu Afonso Jordão; Vivian Suen; Julio Sergio Marchini
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

7.  Novel therapy for non-cirrhotic hyperammonemia due to a spontaneous splenorenal shunt.

Authors:  Shari S Rogal; Angela Hu; Rupal Bandi; Obaid Shaikh
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

8.  Severe Hyperammonemic Encephalopathy Requiring Dialysis Aggravated by Prolonged Fasting and Intermittent High Fat Load in a Ramadan Fasting Month in a Patient with CPTII Homozygous Mutation.

Authors:  P Phowthongkum; C Ittiwut; V Shotelersuk
Journal:  JIMD Rep       Date:  2017-11-21

9.  Asterixis: a study of 103 patients.

Authors:  Gian Pal; Mark M Lin; Robert Laureno
Journal:  Metab Brain Dis       Date:  2014-03-07       Impact factor: 3.584

10.  Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events.

Authors:  Jan Rasmussen; Olav W Nielsen; Allan M Lund; Lars Køber; Høgni Djurhuus
Journal:  J Inherit Metab Dis       Date:  2012-05-08       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.